首页> 美国卫生研究院文献>Neurology and Therapy >Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials
【2h】

Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials

机译:校正至:芬格莫德立即治疗与延迟芬戈莫德治疗对复发-缓解型多发性硬化症的年轻成人患者的长期影响:来自FREEDOMS / FREEDOMSII试验的汇总分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Kaplan–Meier estimates of time to 6 m-CDI ( ) and 6 m-CDI+ ( ) in young adult patients and the overall analysis population from pooled FREEDOMS/FREEDOMS II studies. The Cox regression model was adjusted for sex, age, baseline EDSS and number of relapses in the 2 years prior to the study. Subjects with baseline EDSS score < 2.0 were excluded for 6m-CDI. Subjects with baseline EDSS score ≤ 2.0 were excluded for 6m-CDI+ 6m-CDI 6-month confirmed disability improvement, 6m-CDI+ 6-month confirmed disability improvement-plus, CI confidence interval, EDSS Expanded Disability Status Scale, FTY fingolimod, HR hazard ratio
机译:通过合并的FREEDOMS / FREEDOMS II研究,Kaplan–Meier估计了年轻成年患者和总体分析人群达到6 m-CDI()和6 m-CDI +()的时间。研究前2年对Cox回归模型进行了性别,年龄,基本EDSS基线和复发次数的调整。基线EDSS得分<2.0的受试者被排除在6m-CDI之外。 EDSS基线≤2.0的受试者因6m-CDI + 6m-CDI 6个月确认的残疾改善,6m-CDI + 6个月确认的残疾改善+,CI置信区间,EDSS扩大的残疾状态量表,FTY芬戈莫德,HR危险而被排除在外比

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号